Viewing Study NCT05024318


Ignite Creation Date: 2025-12-25 @ 4:29 AM
Ignite Modification Date: 2026-04-21 @ 9:08 AM
Study NCT ID: NCT05024318
Status: RECRUITING
Last Update Posted: 2024-05-16
First Post: 2021-03-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: NeoAdjuvant Pembrolizumab and STEreotactic Radiotherapy Prior to Nephrectomy for Renal Cell Carcinoma
Sponsor: Peter MacCallum Cancer Centre, Australia
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module